ACEi and ARBS in Hypertension and Heart Failure

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book ACEi and ARBS in Hypertension and Heart Failure by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319097886
Publisher: Springer International Publishing Publication: October 16, 2014
Imprint: Springer Language: English
Author:
ISBN: 9783319097886
Publisher: Springer International Publishing
Publication: October 16, 2014
Imprint: Springer
Language: English

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

More books from Springer International Publishing

Cover of the book Phytotoxicity of Nanoparticles by
Cover of the book Smart Nitrate Sensor by
Cover of the book KI 2017: Advances in Artificial Intelligence by
Cover of the book Recent Trends in Algebraic Development Techniques by
Cover of the book Clean Energy from Waste by
Cover of the book Reviews of Physiology, Biochemistry and Pharmacology Vol. 169 by
Cover of the book Advanced Noncontact Cutting and Joining Technologies by
Cover of the book Achieving Sustainable E-Government in Pacific Island States by
Cover of the book Contactless VLSI Measurement and Testing Techniques by
Cover of the book From QCD Flux Tubes to Gravitational S-matrix and Back by
Cover of the book Industry Trends in Cloud Computing by
Cover of the book Essentials of Partial Differential Equations by
Cover of the book Achieving Consensus in Robot Swarms by
Cover of the book Personal and Organizational Excellence through Servant Leadership by
Cover of the book Quantum Kinetic Theory by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy